The healthcare giant's first-quarter earnings guidance falls below Wall Street estimates, with its key pediatric nutrition business continuing to face significant pressure from lost contracts and rising costs.
Etsy shares face sustained pressure despite solid revenue, as diverging growth expectations and a high P/E ratio spark debate over whether the stock is a hidden gem or a value trap. We analyze the key metrics and market sentiment.
Bio-Techne's shares have rebounded to around $65, but a deep dive into valuation metrics reveals a complex picture. While a discounted cash flow model suggests the stock is near fair value, its sky-high P/E ratio tells a different story, raising questions about its long-term prospects.
PayPal appoints HP's outgoing CEO Enrique Lores as its new chief executive, following disappointing quarterly results and a leadership shake-up aimed at accelerating innovation and execution.
Shares of Soleno Therapeutics (SLNO) rallied nearly 9% after the company framed 2025 as a pivotal year, driven by the launch of its drug VYKAT XR. Despite the recent pop, the stock remains under significant pressure over the past quarter, highlighting the high-stakes bet investors are making on its commercial prospects.
Despite trading significantly below its yearly peak, Netflix's stock is showing signs of a potential near-term recovery, according to options market data. Analysts point to a specific price target around $88 by mid-February, driven by a common trading theory, as a focal point for investors.
The prominent venture capital firm confirms a wave of partner departures resulted from internal disagreements, as it intensifies its focus on artificial intelligence investments and prepares to open a U.S. office, while reaffirming India as its core market.
Snowflake's stock has tumbled nearly 30% over three months, pushing its valuation close to internal estimates and sparking debate among investors. While long-term holders remain in the green, recent momentum has faded, raising questions about its premium pricing in a competitive AI data landscape.
Shares of Helmerich & Payne gained over 5% following the announcement of a planned CEO succession and the reactivation of seven idle drilling rigs in Saudi Arabia, signaling a strategic pivot towards international growth.
Medtronic moves to acquire CathWorks and its non-invasive artery diagnostic system in a deal worth up to $585 million, aiming to strengthen its dominant cardiac portfolio and address a leading cause of heart disease.
Stephens slashes its price target for Atlas Energy Solutions (AESI) to $16, citing a mixed outlook. The stock, already down nearly 50% over the past year, fell further this week amid broader energy sector weakness.
Galaxy Digital Holdings Ltd. reported a net loss of $482 million for Q4 2025, sending its shares down over 6% in pre-market trading. The crypto financial services firm, however, highlighted a resilient full-year adjusted gross profit of $426 million and a robust $2.6 billion liquidity position.
First Solar (FSLR) shares dropped nearly 7% this week following a downgrade by BMO Capital, which cited rising domestic competition and potential new market pressure from Tesla's expanding solar manufacturing plans.
Barclays has lowered its price target for spice giant McCormick & Company, citing heightened concerns over the accelerated rollout of a new enterprise system and persistent tariff-related cost inflation that are set to squeeze 2026 profits.
A 13-year-old boy swam for hours in rough seas to alert rescuers after his mother and two younger siblings were carried away from the Western Australian coast, leading to their dramatic helicopter and boat rescue.
The Walt Disney Company has disclosed the compensation details for its new CEO Josh D’Amaro and President Dana Walden, revealing potential annual packages nearing $38 million and $24 million respectively as the entertainment giant completes its leadership transition.
Merck & Co. delivered robust fourth-quarter results, beating analyst estimates, but its full-year guidance fell short of Wall Street expectations, sending shares lower. The outlook incorporates significant charges from its recent acquisition of Cidara Therapeutics.
The signals from this year's World Economic Forum extend far beyond diplomacy, presenting CEOs with an urgent mandate to overhaul business models designed for a bygone era of global stability.
The House is poised to pass a funding bill to reopen most government agencies, while NASA postpones its crewed moon mission. In Arizona, authorities are investigating the suspected abduction of 'TODAY' anchor Savannah Guthrie's mother.
Stifel analyst Nathan Jones boosted his price target for A.O. Smith to $85 following a stronger-than-expected fourth quarter, even as the water technology company's 2026 revenue forecast fell short of Wall Street expectations. The mixed report highlights the firm's resilience in North America against persistent challenges in its China operations.
